Why Inspire Medical Systems is back on investors' radar

Inspire Medical Systems (INSP) recently reported a strong quarter, with revenue above expectations, 12.2% year over year growth, and a full year guidance raise that ranked highest among its sector peers.

Despite the recent earnings beat and guidance raise, the share price has been under pressure, with a 90 day share price return of 56.0% and a 1 year total shareholder return of 65.5%. This may point to fading momentum as investors reassess risk around reimbursement and earnings expectations.

If this update has you rethinking your exposure to medical technology, it could be a useful moment to look across the sector using our screener of 32 healthcare AI stocks as potential alternatives to research further.

So with the shares down sharply over the past year but trading at a discount to some analyst targets, is Inspire Medical Systems now overlooked value, or are markets already baking in all the future growth you care about?

Most Popular Narrative: 50.2% Undervalued

With Inspire Medical Systems closing at $61.89 and the most followed narrative pointing to a fair value of $124.40, the gap between price and modeled value is wide and hard to ignore.

The analysts have a consensus price target of $144.533 for Inspire Medical Systems based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $230.0, and the most bearish reporting a price target of just $97.0.

Want to see what is sitting underneath that big valuation gap, and why analysts disagree so much on the end point? The narrative leans on projected revenue expansion, higher profit margins and a rich future earnings multiple, all run through a discount rate that brings everything back to today. If you want to understand which of those levers does the heavy lifting, you will need to see the full breakdown.

Result: Fair Value of $124.40 (UNDERVALUED)

However, you still need to weigh real risks, including reimbursement or coding setbacks and slower Inspire V rollout, which could pressure revenue and margins.

Next Steps

If this mix of optimism and worry feels familiar, take a moment to look at the full picture for yourself and move quickly while sentiment is split, starting with 3 key rewards and 2 important warning signs.

Looking for more investment ideas?

If Inspire Medical Systems has sparked your curiosity, do not stop here. Use the Simply Wall St screener to uncover other opportunities that could better fit your style.

• Spot potential mispricings fast by scanning our list of 46 high quality undervalued stocks that combine strong fundamentals with prices that may not fully reflect their profiles.
• Prioritise sleep at night by checking companies in our 63 resilient stocks with low risk scores that score well on financial strength and business stability.
• Get ahead of the crowd by reviewing our screener containing 23 high quality undiscovered gems that the market may not be paying full attention to yet.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.